{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:09:26Z","timestamp":1753891766752,"version":"3.41.2"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background and aim<\/jats:title><jats:p>Paraneoplastic coagulopathy can present as stroke and is associated with specific biomarker changes. Identifying paraneoplastic coagulopathy can help guide secondary prevention in stroke patients, and early cancer detection might improve outcomes. However, unlike ischemic stroke, it remains unclear whether paraneoplastic coagulopathy is associated with transient ischemic attacks (TIA). This study assessed the presence of cancer-related biomarkers in TIA patients and evaluated long-term mortality rates in patients with and without active cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Active cancer was retrospectively identified in consecutive TIA patients treated at a comprehensive stroke center between 2015 and 2019. An association between the presence of cancer and cancer-related biomarkers was assessed using multivariable logistic regression. Long-term mortality after TIA was analyzed using multivariable Cox regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 1436 TIA patients, 72 had active cancer (5%), of which 17 were occult (1.2%). Cancer-related TIA was associated with male gender (adjusted odds ratio [aOR] 2.29, 95% CI 1.12\u20134.68), history of smoking (aOR 2.77, 95% CI 1.34\u20135.7), elevated D-dimer (aOR 1.77, 95% CI 1.26\u20132.49), lactate dehydrogenase (aOR 1.003, 95% CI 1.00\u20131.005), lower leukocyte count (aOR 1.20, 95% CI 1.04\u20131.38), and lower hemoglobin (aOR 1.02, 95% CI 1.00\u20131.04). Long-term mortality was associated with both active cancer (adjusted hazard ratios [aHR] 2.47, 95% CI 1.58\u20133.88) and occult cancer (aHR 3.08, 95% CI 1.30\u20137.32).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Cancer-related TIA is not uncommon. Biomarkers known to be associated with cancer-related stroke also seem to be present in TIA patients. Early identification would enable targeted treatment strategies and could improve outcomes in this patient population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1268131","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:24:21Z","timestamp":1695921861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Transient ischemic attacks in patients with active and occult cancer"],"prefix":"10.3389","volume":"14","author":[{"given":"Morin","family":"Beyeler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Castigliego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Kielkopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madlaine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan A.","family":"Bauer-Gambelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Mujanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Raphael","family":"Meinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kaesmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam R.","family":"Heldner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Seiffge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Pabst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin D.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak B.","family":"Navi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"B\u00fccke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5853\/jos.2019.02278","article-title":"Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms","volume":"22","author":"Bang","year":"2020","journal-title":"J Stroke."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/STROKEAHA.120.032002","article-title":"Cancer and embolic stroke of undetermined source","volume":"4","author":"Navi","year":"2021","journal-title":"Stroke"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.006","article-title":"Predictors of occult cancer in acute ischemic stroke patients","volume":"24","author":"Cocho","year":"2015","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000440730","article-title":"Cancer-associated stroke: the bergen NORSTROKE study","volume":"5","author":"Selvik","year":"2015","journal-title":"Cerebrovasc Dis Extra."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1159\/000316764","article-title":"Acute stroke patients have occult malignancy more often than expected","volume":"3","author":"Uemura","year":"2010","journal-title":"Eur Neurol Published online."},{"key":"B6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1155\/2015\/502089","article-title":"Comparison of enoxaparin and warfarin for secondary prevention of cancer-associated stroke","volume":"2015","author":"Jang","year":"2015","journal-title":"J Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"Guideline for the prevention of stroke in patients with stroke and transient ischemic attack. A guideline from the American heart association\/American stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"B8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1017\/cjn.2021.127","article-title":"Canadian stroke best practice recommendations: secondary prevention of stroke update 2020","volume":"49","author":"Gladstone","year":"2022","journal-title":"Can J Neurol Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"106609","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106609","article-title":"Journal of Stroke and Cerebrovascular Diseases Development of a score for prediction of occult malignancy in stroke patients (occult-5 score)","volume":"31","author":"Beyeler","year":"2022","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/01.str.6.5.564","article-title":"A classification and outline of cerebrovascular diseases","volume":"6","author":"Disorders","year":"1975","journal-title":"II Stroke."},{"key":"B11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/nejmoa1800410","article-title":"Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/jth.14219","article-title":"Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH","volume":"16","author":"Khorana","year":"2018","journal-title":"J Thromb Haemost."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12040917","article-title":"Are patients with active cancer and those with history of cancer carrying the same risks of recurrent VTE and bleeding while on anticoagulants?","volume":"12","author":"Frere","year":"2020","journal-title":"Cancers."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2022.930635","article-title":"Absence of susceptibility vessel sign in patients with malignancy-related acute ischemic stroke treated with mechanical thrombectomy","volume":"13","author":"Beyeler","year":"2022","journal-title":"Front Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.25227","article-title":"Ischemic stroke in cancer patients: a review of an underappreciated pathology","volume":"83","author":"Navi","year":"2018","journal-title":"Ann Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0974-2077.94323","article-title":"Nonmelanoma Skin Cancer","volume":"5","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"key":"B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke."},{"key":"B18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ana.26129","article-title":"Mechanisms of ischemic stroke in patients with cancer : a prospective study","volume":"5","author":"Navi","year":"2021","journal-title":"Ann Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17562864221106362","article-title":"Cancer and stroke : commonly encountered by clinicians, but little evidence to guide clinical approach","volume":"24","author":"Woock","year":"2022"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105366","article-title":"D-dimer and body CT to identify occult malignancy in acute ischemic stroke","volume":"29","author":"Rosenberg","year":"2020"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.595835","article-title":"C-reactive protein and cancer\u2014Diagnostic and therapeutic insights","volume":"11","author":"Hart","year":"2020","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/hed.23535","article-title":"Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer","volume":"36","author":"Campian","year":"2014","journal-title":"Head Neck"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1007\/s00415-021-10528-3","article-title":"Cancer is associated with inferior outcome in patients with ischemic stroke","volume":"268","author":"Seystahl","year":"2021","journal-title":"J Neurol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5853\/jos.2022.02012","article-title":"Explanatory Power and Prognostic Implications of Factors Associated with Troponin Elevation in Acute Ischemic Stroke","volume":"25","author":"Ahn","year":"2023","journal-title":"J Stroke."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3174\/ajnr.A4846","article-title":"Three-Territory DWI acute infarcts: Diagnostic value in cancer-Associated hypercoagulation stroke (trousseau syndrome)","volume":"37","author":"Finelli","year":"2016","journal-title":"Am J Neuroradiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1212\/CPJ.0000000000000603","article-title":"Three Territory Sign: An MRI marker of malignancy-related ischemic stroke (Trousseau syndrome)","volume":"9","author":"Nouh","year":"2019","journal-title":"Neurol Clin Pract."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1268131\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:24:36Z","timestamp":1695921876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1268131\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":27,"alternative-id":["10.3389\/fneur.2023.1268131"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1268131","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"article-number":"1268131"}}